Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Fed Chair Highlights Importance of Flexibility in Economic Forecasts
Fed Chair Highlights Importance of Flexibility in Economic Forecasts
Pickup Truck Rear Safety Rated Poorly in New Study
Pickup Truck Rear Safety Rated Poorly in New Study
Adidas Says It May Write Off Remaining Unsold Yeezy Shoes After Breakup With Ye
Adidas said it might have to write off the remaining 300 million euros ($320 million) worth of Yeezy shoes left unsold after it cut ties with rapper Ye, formerly known as Kanye West.
Ivanka Trump Testifies She Wasn't Involved in Documents Central to Her Father's Civil Fraud Trial
Ivanka Trump began testifying Wednesday in the civil fraud trial that is publicly probing the Trump family business, making an appearance she tried to prevent.
Walmart Introduces Calming Hours
Walmart announced it's looking to create a calm morning shopping experience by turning TV walls to static non-moving images, silencing radios, and dimming store lights.
Report: More Millennials Missing Credit Card Payments
New data found that the number of millennials who are missing their credit card payments is on the rise.
Stocks Rise Slightly as Market Looks to Extend Winning Streak
Stocks rose slightly in Wednesday's opening session as the market sought to extend its winning streak.
Meta Announces New A.I. Transparency Policy
Meta has announced a new policy regarding A.I.-generated advertisements on its platform.
